SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ULB-LAZY BUT LOTOFVALUE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nestegg who wrote (115)5/25/1999 9:34:00 AM
From: PHarris  Read Replies (1) of 117
 
Merger....

biz.yahoo.com

TARZANA, Calif--(BUSINESS WIRE)--May 25, 1999--Unilab Corporation (AMEX: ULB - news) today announced that it
has signed a definitive agreement to merge with UC Acquisition Sub, Inc., a corporation formed by Kelso & Company. Kelso is
a private investment firm based in New York.

The transaction is valued at approximately $420 million, including indebtedness of approximately $145 million which will be
refinanced. Unilab will continue to operate as an independent company under its current name.

Pursuant to the Merger Agreement, all but approximately 1.8 million shares of common stock of the Company (approximately
7% of the Company's post-merger shares outstanding) will be converted into the right to receive $5.85 per share in cash, with
the Company's current stockholders retaining those 1.8 million shares. Unilab currently has approximately 42 million shares of
common stock outstanding, excluding outstanding options and convertible securities. Kelso has the ability to convert the
transaction to all cash consideration. In this event, the Company's current stockholders will receive $5.85 in cash for 100% of
their shares. The transaction is structured to be accounted for as a recapitalization for accounting purposes.

Following the merger, Kelso and its affiliates are expected to own approximately 93% of the Company's outstanding shares.
Kelso and its affiliates will invest approximately $139 million of equity in the transaction.

Unilab's Board of Directors has approved the transaction. BT Alex. Brown Incorporated served as financial advisor to the
Company.

The merger is expected to be completed during the third quarter of 1999 and is subject to approval by the Company's
stockholders, the refinancing of the Company's existing indebtedness and obtaining additional financing to pay the merger
consideration, the expiration of the applicable waiting period under the Hart-Scott Rodino Act and other customary conditions.
A special meeting of Unilab's stockholders will be scheduled as soon as practical following approval of proxy materials by the
Securities and Exchange Commission. An affiliate of Kelso has obtained binding commitments for $160 million in senior bank
financing and $150 million in bridge financing for the transaction.

Unilab Corporation is the largest provider of clinical laboratory testing services in California through its primary testing facilities in
Los Angeles, San Jose and Sacramento and over 300 regional service and testing facilities located throughout the state.

This press release contains certain forward-looking statements, which the Company is making in reliance on the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements
involve risks and uncertainties. Certain of these risks and uncertainties are described in the Company's filings with the Securities
and Exchange Commission.

Any offering of securities in connection with the merger will be made only by means of a prospectus.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext